Science Researcher Update

ISOBM 2015 Oncology in the Biomarker Era: Biology - Diagnostics - Therapy

Written by Stela BCI | Jul 18, 2015 7:19:56 AM
 
Congress - Zakopane, Poland
 
The theme of the 42nd Congress of the ISOBMlinks all fields of cancer research and oncology. Scientists, laboratory medicine specialists and clinicians will have an opportunity to present their latest findings in cancer research, diagnosis and clinical oncology. Interdisciplinary and innovative approaches are much welcome.
The topics will include:
• Serum tumour markers present and future
• Molecular diagnosis/prediction/prognosis
• Genomics-driven approaches
• Epigenetics, microRNAs, free dsRNA
• Biomarker validation
• Molecular Immunological Markers for the Management of Cancer Patients
• Immunotherapy
• Personalised Medicine
• Aniticancer therapies from research to trials to treatment
• Anticancer drugs – new developments, new strategies
• Cancer-related Inflammation and biomarkers
• Microenviroment / metastasis / invasion
• Tumour heterogeneity
• Circulating cancer cells
• Liquid biopsy/Exosomes
• Challenges in interdisciplinary studies
• Biobanking
• IT for Research and Medicine
• Protection of intellectual property
Organization: International Society of Oncology and Biomarkers
ISOBM 2015 Oncology in the Biomarker Era: Biology - Diagnostics - Therapy
 
Sat, Oct 03, 2015 - Wed, Oct 07, 2015
Hotel Belvedere
Droga Do Białego 3, 34-500 Zakopane, Poland
 
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.